Research Repository

See what's under the surface


Assessment of discharge treatment prescribed to women admitted to hospital for hyperemesis gravidarum (2018)
Journal Article
Fiaschi, L., Housley, G., Nelson-Piercy, C., Gibson, J., Raji, A., Deb, S., & Tata, L. (2019). Assessment of discharge treatment prescribed to women admitted to hospital for hyperemesis gravidarum. International Journal of Clinical Practice, 73(1), doi:10.1111/ijcp.13261

Aims: Prescribing drug treatment for the management of hyperemesis gravidarum (HG), the most severe form of nausea and vomiting in pregnancy, remains controversial. Since most manufacturers do not recommend prescribing antiemetics during pregnancy, l... Read More

Stillbirth among women prescribed nicotine replacement therapy in pregnancy: analysis of a large UK pregnancy cohort (2018)
Journal Article
Dhalwani, N. N., Szatkowski, L., Coleman, T., Fiaschi, L., & Tata, L. J. (in press). Stillbirth among women prescribed nicotine replacement therapy in pregnancy: analysis of a large UK pregnancy cohort. Nicotine and Tobacco Research, doi:10.1093/ntr/nty019. ISSN 1462-2203

Objective: To compare risk of stillbirth between maternal smokers and those prescribed NRT during pregnancy. Design: Cross-sectional analysis nested in a pregnancy cohort with longitudinal routinely-recorded medical data. Setting: United Kingdo... Read More

Hospital admission for hyperemesis gravidarum: a nationwide study of occurrence, reoccurrence and risk factors among 8.2 million pregnancies (2016)
Journal Article
Fiaschi, L., Nelson-Piercy, C., & Tata, L. J. (in press). Hospital admission for hyperemesis gravidarum: a nationwide study of occurrence, reoccurrence and risk factors among 8.2 million pregnancies. Human Reproduction, 31(8), doi:10.1093/humrep/dew128. ISSN 0268-1161

STUDY QUESTION: What are the maternal risk factors for hyperemesis gravidarum (HG) hospital admission, readmission and reoccurrence in a following pregnancy? SUMMARY ANSWER: Young age, less socioeconomic deprivation, nulliparity, Asian or Black ethn... Read More

Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring (2015)
Journal Article
Dhalwani, N. N., Szatkowski, L., Coleman, T., Fiaschi, L., & Tata, L. J. (2015). Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics, 135(5), doi:10.1542/peds.2014-2560. ISSN 0031-4005

BACKGROUND AND OBJECTIVES: Nicotine replacement therapy (NRT) is now being used as a smoking cessation aid during pregnancy, although little is known about fetal safety. We assessed the relationship between early pregnancy exposure to NRT or smoking... Read More

Prescribing of nicotine replacement therapy in and around pregnancy: a population-based study using primary care data (2014)
Journal Article
Dhalwani, N. N., Szatkowski, L., Coleman, T., Fiaschi, L., & Tata, L. J. (2014). Prescribing of nicotine replacement therapy in and around pregnancy: a population-based study using primary care data. British Journal of General Practice, doi:10.3399/bjgp14X681361. ISSN 0960-1643

Background Licensing arrangements for nicotine replacement therapy (NRT) in the UK were broadened in 2005 to allow prescribing to pregnant smokers. However, estimates of NRT prescribing in pregnant females in the UK are currently lacking. Aim To... Read More

Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications (2013)
Journal Article
Ban, L., Tata, L. J., Fiaschi, L., & Card, T. R. (2014). Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications. Gastroenterology, 146(1), doi:10.1053/j.gastro.2013.09.061. ISSN 2308-2097

Background & aims: Concerns persist about the risk of major congenital anomalies in children of women with inflammatory bowel disease (IBD), and whether medication use affects risk. We assessed these risks, and variations in use of medications by wom... Read More